1. Home
  2. RVT vs SYRE Comparison

RVT vs SYRE Comparison

Compare RVT & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royce Value Trust Inc.

RVT

Royce Value Trust Inc.

HOLD

Current Price

$16.41

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$47.48

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVT
SYRE
Founded
1986
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
RVT
SYRE
Price
$16.41
$47.48
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$60.13
AVG Volume (30 Days)
224.3K
648.1K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
7.32%
N/A
EPS Growth
N/A
N/A
EPS
2.95
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.12
$10.91
52 Week High
$18.73
$45.79

Technical Indicators

Market Signals
Indicator
RVT
SYRE
Relative Strength Index (RSI) 39.18 69.94
Support Level $15.77 $15.01
Resistance Level $16.50 N/A
Average True Range (ATR) 0.45 2.35
MACD -0.05 0.23
Stochastic Oscillator 25.00 86.51

Price Performance

Historical Comparison
RVT
SYRE

About RVT Royce Value Trust Inc.

Royce Value Trust Inc is a diversified closed-end investment company. It invests in diversified sectors including consumer discretionary, consumer staples, healthcare, financial, IT, telecommunications, and materials. The company's portfolio includes common stocks, preferred stocks, corporate bonds, and repurchase agreements. The company invests in Industrials, Financials, Information Technology, Materials, Health Care, Communication Services, Real Estate and others.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: